AMMONUL pharmaceutical API fine chemical vendors

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Starshine Chemical	⤷ Get Started Free	2023-05-9C06073	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: July 29, 2025

Introduction

AMMONUL (sodium phenylacetate and sodium benzoate) is an FDA-approved medication indicated for the treatment of hyperammonemia, a life-threatening condition characterized by excessively high ammonia levels in the blood. The effectiveness and safety of AMMONUL hinge critically on the quality of its active pharmaceutical ingredients (APIs): sodium phenylacetate and sodium benzoate. Ensuring a reliable, high-quality supply of these APIs is essential for manufacturing consistent, efficacious product batches, particularly given the medical urgency and regulatory constraints associated with ammonia detoxification therapies.

This article explores global sources of bulk APIs for AMMONUL, detailing the key suppliers, manufacturing bases, quality standards, and procurement considerations relevant to pharmaceutical manufacturers, distributors, and healthcare providers.

Overview of API Requirements for AMMONUL

Sodium Phenylacetate and Sodium Benzoate must conform to stringent pharmacopeial standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other relevant quality specifications. They require high purity (typically >99%), low residual solvents, and absence of microbial contamination. Suppliers must comply with Good Manufacturing Practices (GMP) to ensure batch-to-batch consistency and regulatory approval.

Global API Suppliers for Sodium Phenylacetate and Sodium Benzoate

1. North American API Suppliers

North America, particularly the United States and Canada, hosts several notable API manufacturers with established GMP compliance and regulatory approvals.

a. Cambrex Corporation

Location: United States (East Rutherford, NJ)
Strengths: Extensive API manufacturing capacity, GMP-certified facilities, strong regulatory track record.
APIs: Produces both sodium phenylacetate and sodium benzoate for licensed formulations.

b. Patheon (Thermo Fisher Scientific)

Location: USA (North Carolina) and Canada
Strengths: Global footprint, quality assurance, and regulatory compliance for APIs catering to sterile and non-sterile APIs.

c. Broader Regional Suppliers
Canadian and US-based chemical companies also supply phenylacetic acid derivatives; however, their focus often centers on industrial chemicals with some API-grade products available upon specific request.

2. European API Suppliers

Europe has a mature pharmaceutical manufacturing sector with several high-quality API producers.

a. Evonik Industries

Location: Germany
Strengths: GMP-certified API manufacturing, robust quality systems, and extensive experience in specialty chemicals suitable for pharmaceutical APIs.
APIs: May produce sodium benzoate for medicinal use.

b. Sterlab (France)

Location: France
Focus: Wholesale supply of pharmaceutical chemicals, including benzoates and phenylacetates compliant with pharmacopeial standards.

c. Ajinomoto Bauhinia Biotech (ABB)

Location: Taiwan (but included in Asia-Pacific for regional sourcing) with global distribution channels.
Strengths: Known for high purity intermediates and APIs, adherence to GMP standards.

3. Asian API Suppliers

Asia remains a significant hub for bulk chemical APIs, distinguished by cost efficiency and manufacturing capacity.

a. Zhejiang NHU Co., Ltd. (China)

Location: China
Strengths: Large-scale manufacturer of pharmaceutical intermediates and APIs, including benzoic acid derivatives meeting international standards.

b. Shanghai Haohong Pharmaceutical Co., Ltd.

Location: China
Capabilities: Production of sodium benzoate and phenylacetate APIs, with GMP certification and export licenses.

c. A dedicated API manufacturer in India:

Glenmark Pharmaceuticals and Divi's Laboratories

Both firms produce a broad portfolio of APIs with high purity levels, adhering strictly to GMP standards, making them reliable sources for sodium phenylacetate and sodium benzoate.

d. Indian API producers (e.g., Sun Pharma, Aurobindo Pharma)

These companies supply a variety of APIs including benzoates and phenylacetates, certified to international quality standards.

Quality and Regulatory Considerations

High-purity APIs must comply with regulatory standards such as USP, EP, or JP.
Suppliers should provide comprehensive certificates of analysis (CoA), stability data, and batch documentation.
Many suppliers from the US, Europe, and Asia maintain ISO 9001 and GMP certifications.
Regulatory approvals: APIs intended for injectable formulations like AMMONUL must have Drug Master Files (DMFs) filed or approved by agencies such as the FDA or EMA, which enhances supply chain reliability and simplifies regulatory filings.

Supply Chain and Procurement Insights

Consistency: Some vendors offer long-term supply agreements that ensure continuous availability, critical given the urgent clinical needs for hyperammonemia management.
Validation: The quality assurance process involves rigorous validation, including testing for residual solvents, heavy metals, microbiological contamination, and particulate matter.
Cost Dynamics: Asian suppliers tend to offer more competitive pricing, but regulatory compliance and quality assurance are key considerations. The North American and European suppliers often have faster logistics and regulatory familiarity for Western markets.

Emerging and Future Sources

Emerging manufacturers in emerging markets are investing in GMP-compliant facilities for pharma-grade APIs, aiming to address supply gaps and reduce costs. Regulatory bodies are increasingly scrutinizing origin and quality, favoring suppliers with documented GMP compliance and transparent quality control procedures.

Key Factors in Selecting API Sources for AMMONUL

GMP Compliance: Ensure all suppliers have validated GMP certifications aligned with regional regulatory requirements.
Regulatory Filings: Preference for suppliers with approved DMFs or equivalent documentation.
Consistency & Reliability: Long-term supply agreements mitigate risks associated with manufacturing disruptions.
Quality Standards: APIs must meet pharmacopeial grades (USP, EP) with verified high purity and low residual impurities.
Logistics & Lead Time: Consider proximity, shipping capabilities, and customs clearance efficiency.

Conclusion

The sourcing of high-quality bulk APIs for AMMONUL involves a comprehensive assessment of global suppliers, balancing quality, regulatory compliance, cost, and supply chain reliability. Top-tier API manufacturers in North America, Europe, and Asia offer options tailored to these needs. Selecting the optimal source demands rigorous validation processes, clear documentation, and an understanding of regional regulatory landscapes to ensure safe, effective, and consistent hyperammonemia treatment.

Key Takeaways

Reliable API sourcing is critical for the manufacturing of AMMONUL, especially given its life-saving role in hyperammonemia treatment.
North American, European, and Asian API suppliers each have unique strengths, from regulatory compliance to cost effectiveness.
Ensuring GMP compliance, regulatory approval, and high purity standards forms the backbone of any effective API procurement strategy.
Building strong supplier relationships and long-term agreements minimizes supply disruption risks in clinical and hospital settings.
Continuous monitoring of emerging suppliers and manufacturing innovations can provide competitive advantages and ensure supply chain resilience.

FAQs

1. What are the critical quality attributes for APIs used in AMMONUL?
APIs must meet high purity standards (>99%), with minimal residual solvents, heavy metals, and microbial contamination, complying with pharmacopeial standards such as USP or EP.

2. Which regions are the primary sources for GMP-certified sodium phenylacetate and sodium benzoate?
GMP-certified APIs are primarily sourced from North America (US/Canada), Europe (Germany, France), and Asia (China, India), depending on supplier capabilities and regulatory compliance.

3. How do regulatory requirements influence API sourcing for injectable drugs like AMMONUL?
APIs must have validated DMFs, be produced in GMP facilities, and meet strict pharmacopoeial specifications, facilitating regulatory approval and market access.

4. Are there differences in API sourcing costs globally?
Yes. Asian suppliers generally offer lower costs, but regulatory compliance and quality assurance are paramount. North American and European suppliers might incur higher costs but offer established regulatory pathways and faster logistics.

5. What should manufacturers consider when validating a new API supplier?
Key considerations include GMP certification, documented regulatory approvals, comprehensive CoAs, supplier audits, and consistency in quality during initial production runs.

References

[1] U.S. Food and Drug Administration. AMMONUL (sodium phenylacetate and sodium benzoate) Injection.
[2] European Pharmacopoeia. Monographs for sodium benzoate and phenylacetic acid derivatives.
[3] API Providers Profiles and Certification Data, Company Websites (Cambrex, Evonik, Zhejiang NHU).
[4] Global API Market Reports, 2022.

Bulk Pharmaceutical API Sources for AMMONUL